Publicaciones
-
Rössler J, Baselga E, Davila V, Celis-Passini V, Diociaiuti A, El Hachem M, Mestre S, Haeberli D, Prokop A, Hanke C, Loichinger W, Quéré I, Baumgartner I, Niemeyer CM and Kapp FG.
Severe adverse events during sirolimus "off-label" therapy for vascular anomalies
PEDIATRIC BLOOD & CANCER . 68(8): . Nº de citas: 25
-
Buechner J, Grupp SA, Hiramatsu H, Teachey DT, Rives-Solà S, Laetsch TW, Yanik GA, Wood P, Awasthi R, Yi L, Chassot-Agostinho A, Eldjerou LK and De Moerloose B.
Practical guidelines for monitoring and management of coagulopathy following tisagenlecleucel CAR T-cell therapy
blood advances . 5(2): 593-601. Nº de citas: 35
-
Cruz-Martínez O, Caloretti V, Salvador-Hernandez H, Celis-Passini V, Santa-María López V, Morales-La Madrid A, Suñol M, Puerta P, Muchart-Lopez J, Krauel L and Lavarino C.
Synchronous choroid plexus papilloma and Wilms tumor in a girl, disclosing a Li-Fraumeni syndrome
HEREDITARY CANCER IN CLINICAL PRACTICE . 19(1): 1-1.
-
Levine JE, Grupp SA, Pulsipher MA, Dietz AC, Rives-Solà S, Myers GD, August KJ, Verneris MR, Buechner J, Laetsch TW, Bittencourt H, Baruchel A, Boyer MW, De Moerloose B, Qayed M, Davies SM, Phillips CL, Driscoll TA, Bader P, Schlis K, Wood PA, Mody R, Yi L, Leung M, Eldjerou LK, June CH and Maude SL.
Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia
Journal for ImmunoTherapy of Cancer . 9(8): 2287. Nº de citas: 37
-
Torrents S, Alonso L, Vives J, Rodríguez L, Moron-Cazalilla G, Elorza-Alvarez I, Uria ML, Benitez MI, Parody R, Orti G, Trabazo M, Fernandez-Sojo J, Badell-Serra I and Querol S.
Good Response Rates of WJ-MSC, Comparable to BMMSC, in the Treatment of Refractory GVHD
BONE MARROW TRANSPLANTATION . 55(s1): 269-270.
-
Vega-García N, Benito R, Esperanza-Cebollada E, Llop M, Robledo C, Vicente-Garces C, Alonso J, Barragán E, Fernandez-Isern G, Hernández-Sánchez JM, Martín-Izquierdo M, Maynou-Fernández J, Minguela A, Montaño A, Ortega M, Torrebadell-Burriel M, Cervera J, Sánchez J, Jiménez-Velasco A, Riesco S, Hernández-Rivas JM, Lassaletta Á, Fernández JM, Rives-Solà S, Dapena JL, Ramírez M and Camós-Guijosa M.
Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia
Journal of Personalized Medicine . 10(4): 244. Nº de citas: 1
-
Turrubiartes-Martinez, E, Bodega-Mayor, I, Delgado-Wicke, P, Molina-Jimenez, F, Casique-Aguirre, D, Gonzalez-Andrade, M, Rapado, I, Camós-Guijosa M, Diaz-de-Heredia, C, Barragan, E, Ramirez-Orellana, M, Aguado, B, Figuera, A, Martinez-Lopez, J and Fernandez-Ruiz, E.
TYK2 Variants in B-Acute Lymphoblastic Leukaemia
GENES . 11(12): . Nº de citas: 5
-
Cuadros M, García DJ, Andrades A, Arenas AM, Coira IF, Baliñas-Gavira C, Peinado P, Rodríguez MI, Álvarez-Pérez JC, Ruiz-Cabello F, Camós-Guijosa M, Jiménez-Velasco A and Medina PP.
LncRNA-mRNA Co-Expression Analysis Identifies AL133346.1/CCN2 as Biomarkers in Pediatric B-Cell Acute Lymphoblastic Leukemia
Cancers . 12(12): 3803. Nº de citas: 7
-
Vilaseca M, Burgos-Fernandez FJ, Rey-Barroso L, Roldan-Molina M, Gassiot S, Sarrate E, Isola I and Ruiz-Llobet A.
Hyperspectral imaging for skin cancer and blood disorders diagnosis.
Asian Journal of Physics . 29(10-12): 1-20.
-
Salvador, PP, Benjamin, RS, Manel, BG, Angel, FRS, Montserrat, TE, Badell-Serra I, Jordi, SC and Jorge, SG.
APPLICATION OF THE CLINICAL EXOMA "SANT PAU" FOR THE DIAGNOSIS OF HEMOLITIC ANEMIAS AND HEREDITARY IRON METABOLISM DISORDERS
HAEMATOLOGICA . 105: 33-33.